First Drugs Selected for Price Negotiations Under The Inflat

The Inflation Reduction Act’s Medicare Drug Price Negotiation Program will kick off next week. The statute sets a deadline of September 1, 2023 for the Secretary of Health and Human...

Related Keywords

White House , District Of Columbia , United States , Michigan , Dayton , Ohio , America Ph , Matt Wetzel , Ohio Chamber , Astrazeneca Pharmaceuticals , Astellas Pharma Us Inc , No Legislative Authority , Drug Price Negotiation Program The , National Infusion Center Association , Drug Price Negotiation Program , B Program , Astrazeneca , Michigan Chamber , Biosimilars Forum , National Infusion Center Assoc , Centers For Medicare Medicaid Services , Coverage Gap Discount Program , Boehringer Ingelheim Pharmaceuticals Inc , Human Services , Global Colon Cancer Association , Janssen Pharmaceuticals Inc , Goodwin Life Sciences Regulatory Compliance , Dayton Area Chamber , Us Chamber , Bristol Myers Squibb Co , Merck Co Inc , Inflation Reduction Act , Medicare Drug Price Negotiation Program , Price Negotiation Program , Medicaid Services , Goodwin Life Sciences Regulatory , Medicare Modernization Act , Maximum Fair Price , Drug Price Negotiation , Biosimilar Delay , Reference Drug , Biosimilar Manufacturer , Reference Manufacturer , Drug Selection , Maximum Fair , Price Negotiation , Myers Squibb , Ingelheim Pharmaceuticals , Area Chamber Of Commerce , Infusion Center , Pharmaceutical Research , Fifth Amendment , Due Process Clause , Boehringer Ingelheim , Single Source , Big Molecule Watch ,